Sample sizes varied substantially, ranging from 30 to 134 participants, reflecting differences in study scope and feasibility across settings
Compared to GLP-1 Agonists: Weight management peptides like semaglutide and tirzepatide have demonstrated weight loss efficacy superior to AOD-9604 in clinical trials, but they also have distinct side effect profiles
Capacitors: Use power capacitors to help handle burst spikes and protect batteries
Without healthy lifestyle modifications, theres an increased risk of regaining weight once the medication is discontinued
Sanyal, Jian-Gao Fan, Laurent Castera, Victor de Ldinghen, Michelle Lai, Xiao-Dong Zhou, Vincent Wai-Sun Wong, Ming-Hua Zheng, on behalf of VCTE-Prognosis Study Group Clin Mol Hepatol 2026;32(3):1333-1348